The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
DynAMo: A dynamic allocation modular sequential trial of approved and promising therapies in men with metastatic CRPC.
 
Paul Vincent Viscuse
No Relationships to Disclose
 
Rebecca Tidwell
Research Funding - Galera Therapeutics (Inst)
 
Jingjing Liu
No Relationships to Disclose
 
Shuai Guo
No Relationships to Disclose
 
Haswanth Vundavilli
No Relationships to Disclose
 
Miao Zhang
No Relationships to Disclose
 
Sumit Kumar Subudhi
Stock and Other Ownership Interests - Apricity Health
Honoraria - Amgen; Apricity Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Dava Oncology; Dendreon; Exelixis; Janssen; Parker Institute for Cancer Immunotherapy; Polaris; Society for Immunotherapy of Cancer
Consulting or Advisory Role - Amgen; Apricity Health; AstraZeneca; Bayer; Bristol-Myers Squibb; Dava Oncology; Dendreon; Janssen; Polaris; Valeant/Dendreon
Research Funding - AstraZeneca; Bristol-Myers Squibb; Janssen
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Compugen; Dava Oncology; Dendreon; Janssen; Parker Institute for Cancer Immunotherapy; Society for Immunotherapy of Cancer
 
Amado J. Zurita
Honoraria - Janssen; Pfizer
Consulting or Advisory Role - AstraZeneca; Bayer
Research Funding - Infinity Pharmaceuticals
 
Paul Gettys Corn
Research Funding - Janssen Oncology (Inst)
 
Shi-Ming Tu
Consulting or Advisory Role - Janssen Biotech
 
John C. Araujo
No Relationships to Disclose
 
Jennifer Wang
No Relationships to Disclose
 
Eleni Efstathiou
Honoraria - Astellas Pharma; Janssen-Cilag; Merck; Pfizer; Sanofi; Takeda
Consulting or Advisory Role - AstraZeneca; AstraZeneca; Bayer; Janssen Oncology; Myovant Sciences; Sanofi; Tokai Pharmaceuticals
Research Funding - Janssen-Cilag
 
Jianbo Wang
No Relationships to Disclose
 
Patrick Glen Pilié
Consulting or Advisory Role - Novartis
Patents, Royalties, Other Intellectual Property - Patent Pending- biomarker
 
Patricia Troncoso
No Relationships to Disclose
 
Jianhua Zhang
No Relationships to Disclose
 
Wenyi Wang
Stock and Other Ownership Interests - Genomic Health
Research Funding - Curis
 
Christopher Logothetis
Honoraria - Amgen; Bayer; Merck Sharp & Dohme
Consulting or Advisory Role - Amgen; Bayer; Exelixis; Merck Sharp & Dohme
Research Funding - Aragon Pharmaceuticals (Inst); Janssen; Novartis; ORIC Pharmaceuticals (Inst)
 
Ana Aparicio
Honoraria - American Cancer Society; Amgen; Astellas Pharma; AstraZeneca; Biosense Webster (I); Boston Scientific (I); Daiichi Sankyo Inc; Janssen Research & Development
Consulting or Advisory Role - American Cancer Society; Amgen; Astellas Pharma; AstraZeneca; Biosense Webster (I); Boston Scientific (I); Daiichi Sankyo Inc.; Janssen Research & Development
Speakers' Bureau - Biosense Webster (I); Boston Scientific (I)
Research Funding - BioSense Webster (I); Boston Scientific (I); Bristol-Myers Squibb (Inst); Hansen Medical (I); Janssen (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Two (I)
Travel, Accommodations, Expenses - Biosense WEbster (I)